Cleared Traditional

K800299 - FERRITIN RIA KIT

K800299 is the FDA 510(k) clearance for FERRITIN RIA KIT by Amersham Corp.. It is a Class 2 Immunology device (product code DBF) cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K800299 · Amersham Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1980
Decision
21d
Days
Class 2
Risk

K800299 is an FDA 510(k) clearance for the FERRITIN RIA KIT. Classified as Ferritin, Antigen, Antiserum, Control (product code DBF), Class II - Special Controls.

Submitted by Amersham Corp. (Mchenry, US). The FDA issued a Cleared decision on March 3, 1980 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5340 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Amersham Corp. devices

Submission Details

510(k) Number K800299 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 11, 1980
Decision Date March 03, 1980
Days to Decision 21 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d faster than avg
Panel avg: 104d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DBF Ferritin, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBF Ferritin, Antigen, Antiserum, Control

All 63
Devices cleared under the same product code (DBF) and FDA review panel - the closest regulatory comparables to K800299.
FERRIZYME FERRITIN ENZYME IMMUNOASSAY
K801676 · Abbott Laboratories · Aug 1980
FERRITIN RIA KIT
K801580 · Diagnostic Products Corp. · Aug 1980
FERRITIN CONTROLS CODE QAS.104
K800657 · Amersham Corp. · Apr 1980
CENTRIA FERRITIN RIA
K792449 · Union Carbide Corp. · Dec 1979
FERRITIN RADIOIMMUNOASSAY
K792442 · Dade, Baxter Travenol Diagnostics, Inc. · Dec 1979
VENTRE/SEP FERRITIN RIA
K790447 · Ventrex Laboratories, Inc. · Apr 1979